Depression, Anxiety, and Stress Among Patients With Covid-19: A Cross-Sectional Study Publisher Pubmed



Moayed MS¹ ; Vahedianazimi A¹ ; Mirmomeni G² ; Rahimibashar F³ ; Goharimoghadam K⁴ ; Pourhoseingholi MA⁵ ; Abbasifarajzadeh M⁶ ; Hekmat M⁷ ; Sathyapalan T⁸ ; Guest PC⁹ ; Sahebkar A^{10, 11, 12, 13}
Source: Advances in Experimental Medicine and Biology Published:2021

Abstract

Aim: Patients with confirmed COVID-19 infection can develop several psychological consequences. Epidemiological data on mental health and psychological disorder inpatients infected with COVID-19 pneumonia are not available in Iranian patients. The purpose of this study was to evaluate the anxiety, stress, and depression of patients with COVID-19. Material and Methods: This cross-sectional survey was conducted in 2020. All confirmed patients with COVID-19 were included in the study by census sampling. Assessment of depression, stress, and anxiety was performed using the DASS-21 questionnaire. All statistical analyses were performed using R version 3.5.1. Results: The questionnaires were completed by 221 patients with COVID-19 infection (204 males, 17 females). The mean age was 45.90 ± 7.73 years. Our results indicated that the mean scores of depression and anxiety were at “extremely severe” levels, while stress levels were “severe.” The prevalence of “extremely severe” symptoms of depression and anxiety was 54.29% and 97.29%, respectively. The prevalence of severe stress was 46.61%. Conclusion: In this study, patients infected with COVID-19 reported severe and extremely severe experience psychological distress. Further studies should focus on the combined use of psychological and molecular biomarker testing to increase accuracy. Overall, the findings demonstrate the necessity of special intervention programs for the confirmed patients with emerging infectious disease COVID-19 to promote mental health needs. © 2021, The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG.